2/9
01:12 pm
exas
Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders
Low
Report
Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders
2/9
11:40 am
exas
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—EXAS, SNDA, FSUN, and TBN
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—EXAS, SNDA, FSUN, and TBN
2/8
06:06 am
exas
A $700 blood test promises to detect 50 different kinds of cancer. The results come with major caveats. [Business Insider]
Low
Report
A $700 blood test promises to detect 50 different kinds of cancer. The results come with major caveats. [Business Insider]
2/6
09:54 pm
exas
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences' '746 Patent [Yahoo! Finance]
Low
Report
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences' '746 Patent [Yahoo! Finance]
2/3
02:40 pm
exas
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests [Yahoo! Finance]
Low
Report
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests [Yahoo! Finance]
2/3
02:32 pm
exas
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
Low
Report
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
2/3
09:23 am
exas
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide [Yahoo! Finance]
Low
Report
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide [Yahoo! Finance]
2/3
09:03 am
exas
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide
Low
Report
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide
2/3
08:40 am
exas
Multiple Tailwinds Lifted Exact Sciences Corporation (EXAS) in 2025 [Yahoo! Finance]
Low
Report
Multiple Tailwinds Lifted Exact Sciences Corporation (EXAS) in 2025 [Yahoo! Finance]
2/3
07:12 am
exas
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/2
05:16 pm
exas
Halper Sadeh LLC Reminds Shareholders of EXAS, DVN, NFBK of the Firm’s Investigations
Low
Report
Halper Sadeh LLC Reminds Shareholders of EXAS, DVN, NFBK of the Firm’s Investigations
2/2
03:30 pm
exas
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS
1/27
08:02 am
exas
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement [Yahoo! Finance]
Low
Report
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement [Yahoo! Finance]
1/26
03:56 am
exas
Alger Small Cap Growth Fund Q4 2025 Portfolio Update [Seeking Alpha]
Low
Report
Alger Small Cap Growth Fund Q4 2025 Portfolio Update [Seeking Alpha]
1/24
07:11 pm
exas
A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
1/22
12:27 pm
exas
Abbott posts Q4 sales below expectations [Yahoo! Finance]
Low
Report
Abbott posts Q4 sales below expectations [Yahoo! Finance]
1/21
04:52 pm
exas
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
1/21
03:58 pm
exas
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
1/21
06:19 am
exas
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
Low
Report
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
1/20
07:17 am
exas
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Mizuho.
Low
Report
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Mizuho.
1/16
02:02 pm
exas
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
Low
Report
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
1/10
07:02 pm
exas
Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge [Yahoo! Finance]
Low
Report
Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge [Yahoo! Finance]
1/9
02:11 pm
exas
Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
1/9
09:07 am
exas
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned [Yahoo! Finance]
Low
Report
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned [Yahoo! Finance]
1/8
12:48 pm
exas
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights